Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Henry Khederian

Why Quantum BioPharma (QNTM) Stock Is Soaring Today

Pharmacy,,Pills,And,Box,With,Healthcare,Store,,Shelf,And,Prescription

Shares of Quantum BioPharma Ltd (NASDAQ:QNTM) are on watch Monday morning following a series of updates regarding its lead drug candidate for multiple sclerosis, Lucid-MS. Here’s what investors need to know.

What To Know: The primary catalyst is Monday’s announcement of an agreement with a leading contract development and manufacturing organization to produce an oral formulation of Lucid-MS for its upcoming Phase 2 clinical trial. This move marks a critical step toward testing the drug’s efficacy in humans.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.